Answers are grounded in this paper and cite their sources.
Review reveals enhancements in oral drug delivery using nanoparticulate carriers, indicating improved treatment options.
The introduction of nanoparticulate carriers (NPC) in the pharmaceutic and nutraceutic fields has changed the definitions of disease management and treatment, diagnosis, as well as the supply food chain in the agri-food sector. NPC composed of synthetic polymers, proteins or polysaccharides gather interesting properties to be used for oral administration of pharmaceutics and nutraceutics. Oral administration remains the most convenient way of delivering drugs (e.g. peptides, proteins and nucleic acids) since these suffer similar metabolic pathways as food supply. Recent advances in biotechnology have produced highly potent new molecules however with low oral bioavailability. A suitable and promising approach to overcome their sensitivity to chemical and enzymatic hydrolysis as well as the poor cellular uptake, would be their entrapment within suitable gastrointestinal (GI) resistant NPC. Increasing attention has been paid to the potential use of NPC for peptides, proteins, antioxidants (carotenoids, omega fatty acids, coenzyme Q1 0), vitamins, probiotics, for oral administration. This review focuses on the most important materials to produce NPC for oral administration, and the most recentachievements in the productiontechniques and bioactives successfully delivered by these means.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: